The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial

• Egile Nagusiak: Zoya Huschtscha (Egilea), Jessica Silver (Egilea), Michael Gerhardy (Egilea), Charles S. Urwin (Egilea), Nathan Kenney (Egilea), Viet Hung Le (Egilea), Jackson J. Fyfe (Egilea), Simon A. Feros (Egilea), Andrew C. Betik (Egilea), Christopher S. Shaw (Egilea), Luana C. Main (Egilea), Gavin Abbott (Egilea), Sze-Yen Tan (Egilea), Anthony May (Egilea), Craig M. Smith (Egilea), Vicky Kuriel (Egilea), Jackson Barnard (Egilea), D. Lee Hamilton (Egilea)
• Formatua: Liburua
• Argitaratua: SpringerOpen, 2024-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Palmitoylethanolamide (PEA) has analgesic/anti-inflammatory properties that may be a suitable alternative to over-the-counter (OTC) non-steroidal analgesics/anti-inflammatories. While OTC pain medications can impair strength training adaptations, the mechanism of action of PEA is...